This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Innovations of Yasuo Shimazaki: Pioneering Solid Dispersion Technology
Introduction: Yasuo Shimazaki, an accomplished inventor based in Takarazuka, Japan, has made a significant contribution to the pharmaceutical industry with his innovative work. As a member of Fujisawa Pharmaceutical Company, Ltd., he has dedicated his career to advancing drug delivery systems, notably through his patent related to the solid dispersion composition of the FR-900506 substance.
Latest Patents: One of Yasuo Shimazaki's notable patents is for the solid dispersion composition of the FR-900506 substance. This invention pertains to a composition comprising the FR-900506 substance and a water-soluble hydroxypropyl methylcellulose. The composition allows for effective dispersion of the FR-900506 substance, with a specific ratio of the two components, ranging from 1:0:1 to 1:20 by weight. This innovation plays a crucial role in enhancing the solubility and bioavailability of pharmaceutical compounds.
Career Highlights: Yasuo Shimazaki has shown remarkable dedication within Fujisawa Pharmaceutical Company, Ltd., where he has been pivotal in developing various formulations to improve drug efficacy. His work in solid dispersion technology exemplifies the intersection of innovation and practical application in the pharmaceutical field.
Collaborations: Throughout his career, Shimazaki has collaborated with esteemed colleagues such as Yoshio Ueda and Fumio Shimojo. These partnerships have fostered a creative environment that allows for the sharing of ideas and techniques, further propelling the advancements in their respective fields.
Conclusion: Yasuo Shimazaki stands out as a key figure in the realm of pharmaceutical innovations. His work on the solid dispersion composition of the FR-900506 substance showcases not only his inventive spirit but also his commitment to enhancing drug delivery systems. As a dedicated member of Fujisawa Pharmaceutical Company, Ltd., his contributions will undoubtedly continue to influence the industry for years to come.